Dismal long-term prognosis for children with refractory acute myeloid leukaemia treated with gemtuzumab ozogamicin and stem cell transplantation: where now?

Authors: Sibson, Keith1; Steward, Colin2; Moppett, John2; Cornish, Jacqueline2; Goulden, Nick3

Source: British Journal of Haematology, Volume 146, Number 3, August 2009 , pp. 342-344(3)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Keywords: acute leukaemia; AML; childhood leukaemia; stem cell transplantation

Document Type: Correspondence

DOI: http://dx.doi.org/10.1111/j.1365-2141.2009.07750.x

Affiliations: 1: Department of Haematology, University College London Hospital, London 2: Paediatric Haematology and Oncology, Bristol Royal Hospital for Children, Bristol 3: Paediatric Haematology, Great Ormond Street Hospital, London, UK.

Publication date: 2009-08-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page